Chapter 23 Pharmacology of TMS

Supplements to Clinical Neurophysiology

Volumn 56, Issue C, 2003, Pages 226-231

  Ziemann, Ulf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957128269     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70226-0     Document Type: Article

References (41)

1. Boroojerdi B., Battaglia F., Muellbacher W., and Cohen L.G. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin. Neurophysiol. 112 (2001) 931-937
2. Cantello R., Gianelli M., Civardi C., and Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 42 (1992) 1951-1959
3. Chen R., Samii A., Canos M., Wassermann E.M., and Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 49 (1997) 881-883
4. Di Lazzaro V., Oliviero A., Profice P., Saturno E., Pilato F., Insola A., Mazzone P., Tonali P., and Rothwell J.C. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr. Clin. Neurophysiol. 109 (1998) 397-401
5. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburrini G., Tonali P., and Rothwell J.C. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin. Neurophysiol. 111 (2000) 794-799
6. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., Tonali P., and Rothwell J.C. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in human motor cortex. Exp. Brain Res. 135 (2000) 455-461
7. Di Lazzaro V., Oliviero A., Tonali P.A., Marra C., Daniele A., Profice P., Saturno E., Pilato F., Masullo C., and Rothwell J.C. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59 (2002) 392-397
8. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Pilato F., Zito G., Dileone M., Nicoletti R., Pasqualetti P., and Tonali P.A. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J. Physiol. (2003)
9. Fisher R.J., Nakamura Y., Bestmann S., Rothwell J.C., and Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp. Brain Res. 143 (2002) 240-248
10. Hanajima R., Ugawa Y., Terao Y., Enomoto H., Shiio Y., Mochizuki H., Furubayashi T., Uesugi H., Iwata N.K., and Kanazawa I. Mechanisms of intracortical I-wave facilitation elicited with paired- pulse magnetic stimulation in humans. J. Physiol. 538 (2002) 253-261
11. Herwig U., Bräuer K., Connemann B., Spitzer M., and Schönfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacol. 164 (2002) 228-232
12. Ilic T.V., Korchounov A., and Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin reuptake inhibitor sertraline. Neurosci. Lett. 319 (2002) 116-120
13. Ilic T.V., Meintzschel F., Cleff U., Ruge D., Kessler K.R., and Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J. Physiol. 545 1 (2002) 153-167
14. Ilic T.V., Korchounov A., and Ziemann U. Methylphenydate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 14 (2003) 773-776
15. Inghilleri M., Berardelli A., Marchetti P., and Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp. Brain Res. 109 (1996) 467-472
16. Korchounov A., Ilic T.V., and Ziemann U. The alpha2-adrenergic agonist guanfacine reduces excitability of human motor cortex through disfacilitation and increase of inhibition. Clin. Neurophysiol. 114 in press (2003)
17. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., and Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. (Lond.) 471 (1993) 501-519
18. Liepert J., Schwenkreis P., Tegenthoff M., and Malin J.-P. The glutamate antagonist Riluzole suppresses intracortical facilitation. J. Neural. Transm. 104 (1997) 1207-1214
19. Liepert J., Schardt S., and Weiller C. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects. Neurosci. Lett. 300 (2001) 149-152
20. Mavroudakis N., Caroyer J.M., Brunko E., and Zegers de Beyl D. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 93 (1994) 428-433
21. Moll G.H., Heinrich H., and Rothenberger A. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta. Psychiatr. Scand. 107 (2003) 69-72
22. Plewnia C., Bartels M., Cohen L., and Gerloff C. Noradrenergic modulation of human cortex excitability by the presynaptic alpha(2)-antagonist yohimbine. Neurosci. Lett. 307 (2001) 41-44
23. Plewnia C., Hoppe J., Hiemke C., Bartels M., Cohen L., and Gerloff C. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci. Lett. 330 (2002) 231-234
24. Priori A., Berardelli A., Inghilleri M., Accornero N., and Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 117 (1994) 317-323
25. Reis J., Tergau F., Hamer H.M., Muller H.H., Knake S., Fritsch B., Oertel W.H., and Rosenow F. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43 (2002) 1149-1156
26. Schwenkreis P., Witscher K., Janssen F., Addo A., Dertwinkel R., Zenz M., Malin J.-P., and Tegenthoff M. Influence of the N-methyl-D-aspartate antagonist mementine on human motor cortex excitability. Neurosci. Lett. 270 (1999) 137-140
27. Schwenkreis P., Liepert J., Witscher K., Fischer W., Weiller C., Malin J.-P., and Tegenthoff M. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. Exp. Brain Res. 135 (2000) 293-299
28. Siebner H.R., Dressnandt J., Auer C., and Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21 (1998) 1209-1212
29. Sohn Y.H., Kaelin-Lang A., Jung H.Y., and Hallett M. Effect of levetiracetam on human corticospinal excitability. Neurology 57 (2001) 858-863
30. Tokimura H., Ridding M.C., Tokimura Y., Amassian V.E., and Rothwell J.C. Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex. Electroencephalogr. Clin. Neurophysiol. 101 (1996) 263-272
31. Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., Mazzone P., Tonali P., and Rothwell J.C. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J. Physiol. 523 (2000) 503-513
32. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J. Physiol. (Lond.) 517 (1999) 591-597
33. Wischer S., Paulus W., Sommer M., and Tergau F. Piracetam affects facilitatory I-wave interaction in the human motor cortex. Clin. Neurophysiol. 112 (2001) 275-279
34. Ziemann U., Bruns D., and Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci. Lett. 208 (1996) 187-190
35. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp. Brain Res. 109 (1996) 127-135
36. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann. Neurol. 40 (1996) 367-378
37. Ziemann U., Rothwell J.C., and Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J. Physiol. (Lond.) 496 (1996) 873-881
38. Ziemann U., Tergau F., Bruns D., Baudewig J., and Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr. Clin. Neurophysiol. 105 (1997;) 430-437
39. Ziemann U., Chen R., Cohen L.G., and Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51 (1998) 1320-1324
40. Ziemann U., Tergau F., Wassermann E.M., Wischer S., Hildebrandt J., and Paulus W. Demonstration of facilitatory I-wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J. Physiol. (Lond.) 511 (1998) 181-190
41. Ziemann U., Tergau F., Wischer S., Hildebrandt J., and Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr. Clin. Neurophysiol. 109 (1998) 321-330